bluecompanion eHealth project
  • Home
  • About Us
    • Vision
    • Logo & Visual Identity
    • Team
    • Privacy
    • Internal Utility
  • Projects
    • SARCOPENIC OBESITY REGISTRY
    • PARENT PROJECT REGISTRY
    • GEROCOVID
    • SCOTTY
  • Events
  • Pictures
  • Bibliography
  • Contact Us
Sign In
 Coronavirus SARS CoV 2 Gerocovid link
 
 
cartina2
 
 
 
 
 
 
FDA - Vaccines and Related Biological Products Advisory Committee - 10/12/2020 - YouTube

EMA - Public stakeholder meeting: development and authorisation of safe and effective COVID-19 vaccines in the EU | European Medicines Agency

 
 
GENERAL COVID-19 SELECTED PAPERS

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK 
Oxford–AstraZeneca COVID-19 vaccine efficacy
 Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
  16 march 2020 - Imperial College COVID-19 Response Team
 
 
"COVID-19 epidemic. 2 December 2020 national update” (pdf)

 

  • +44 7576315434
  • info@bluecompanion.eu
© 2025 BlueCompanion - BLUECOMPANION Ltd 12a Neville Court, Abbey road NW89DD London, UK - BLUECOMPANION France 41 route de la Bernon, 78440 Jambville, France
bluecompanion eHealth project
Sign In
  • Home
  • About Us
    • Vision
    • Logo & Visual Identity
    • Team
    • Privacy
    • Internal Utility
  • Projects
    • SARCOPENIC OBESITY REGISTRY
    • PARENT PROJECT REGISTRY
    • GEROCOVID
    • SCOTTY
  • Events
  • Pictures
  • Bibliography
  • Contact Us
    • CHILE SP
    • CHILE PHOCA "
  • +44 7576315434
  • info@bluecompanion.eu